However, in a recent retrospective study conducted on a large series of 169 metastatic PPGLs, the authors did not confirm SDHB mutation as a major prognostic parameter in metastatic disease, suggesting the potential role of other molecular events in tumor progression [4]. This evidence concerns the gene SDHB and metastatic neoplasm.